These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16935593)

  • 1. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
    Chen PL; Hsiao CH; Chen JT; Lu DW; Chen WY
    Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients.
    Chen PL; Chen JT; Lu DW; Chen YC; Hsiao CH
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):182-7. PubMed ID: 16808679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using apraclonidine in diagnosing Horner syndrome in children.
    Sueke H; Chandna A
    Am J Ophthalmol; 2010 May; 149(5):869; author reply 870. PubMed ID: 20399934
    [No Abstract]   [Full Text] [Related]  

  • 4. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A; Borruat FX
    Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.
    Koc F; Kavuncu S; Kansu T; Acaroglu G; Firat E
    Br J Ophthalmol; 2005 Nov; 89(11):1442-4. PubMed ID: 16234449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.
    Bacal DA; Levy SR
    Arch Ophthalmol; 2004 Feb; 122(2):276-9. PubMed ID: 14769608
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical apraclonidine to diagnose Bernard-Horner syndrome.
    Kocabora M; Gocmez E; Taskapili M
    Bull Soc Belge Ophtalmol; 2009; (312):9-15. PubMed ID: 19927485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke.
    Lebas M; Seror J; Debroucker T
    J Neuroophthalmol; 2010 Mar; 30(1):12-7. PubMed ID: 20182200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of digital pupillometry for diagnosis of Horner syndrome.
    Yoo YJ; Yang HK; Hwang JM
    PLoS One; 2017; 12(6):e0178361. PubMed ID: 28575101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
    Watts P; Satterfield D; Lim MK
    J AAPOS; 2007 Jun; 11(3):282-3. PubMed ID: 17572343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM; Aouchiche R; Freedman KA
    Arch Ophthalmol; 2003 Aug; 121(8):1201-3. PubMed ID: 12912704
    [No Abstract]   [Full Text] [Related]  

  • 12. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM
    Arch Ophthalmol; 2005 Apr; 123(4):578; author reply 578. PubMed ID: 15824244
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.
    Koc F; Kansu T; Kavuncu S; Firat E
    J Neuroophthalmol; 2006 Mar; 26(1):25-9. PubMed ID: 16518162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular effects of apraclonidine in Horner syndrome.
    Morales J; Brown SM; Abdul-Rahim AS; Crosson CE
    Arch Ophthalmol; 2000 Jul; 118(7):951-4. PubMed ID: 10900109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to topical apraclonidine in children with glaucoma.
    Wright TM; Freedman SF
    J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of apraclonidine in the diagnosis of Horner syndrome].
    Pérez-Iñigo MA; González I; Fernández FJ; Díaz S; Ferrer C; Alias E; Honrubia FM
    Arch Soc Esp Oftalmol; 2009 Feb; 84(2):105-8. PubMed ID: 19253181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraclonidine for the pharmacologic confirmation of acute Horner syndrome.
    Nguyen MTB; Farahvash A; Zhang A; Micieli JA
    J Neurol Sci; 2020 Dec; 419():117190. PubMed ID: 33075593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 0.5% apraclonidine on ptosis in Horner syndrome.
    Garibaldi DC; Hindman HB; Grant MP; Iliff NT; Merbs SL
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):53-5. PubMed ID: 16418668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching NeuroImages: Positive apraclonidine test in Horner syndrome.
    Shin RK; Cheek AG
    Neurology; 2011 May; 76(20):e100. PubMed ID: 21576682
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic.
    Eldib AA; Patil P; Nischal KK; Mitchell ER; Hiasat JG; Pihlblad MS
    J AAPOS; 2021 Dec; 25(6):336.e1-336.e4. PubMed ID: 34737082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.